Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update
Neurologia i Neurochirurgia Polska · 30.10.2026 · 60 (5) · 538-550
DOI: 10.5603/pjnns.111529 ↗Kurz gefasst
Leitlinie in der Zeitschrift Neurologia i Neurochirurgia Polska, online erschienen am 30.10.2026. Verfasst von Alicja Kalinowska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroimmunology, Institute of Neurological Disorders, Poznan University of Medical Sciences, Poznan, Poland. akalinowska@ump.e…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Pregnancy Complications, Family Planning Services.
Abstract (Originalsprache)
Introduction. Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the Central Nervous System that most commonly affects females of reproductive age. Therefore, the issue of family planning is relevant in this population, especially in the context of starting and planning future disease modifying therapy (DMT), so that the risks to mother and child are minimized, while reproductive goals are met. State of the art. Over the recent years the number of pregnancies in MS women has been increasing, as opposed to the trend in the general population. This is a result of several advancements in MS treatment and the growing body of evidence regarding DMT safety in the context of pregnancy and breastfeeding. It is not justified to delay DMT or to discourage patients from pregnancy planning. Instead, a highly individualized approach is recommended. The gynecological and obstetric approach to prenatal care and delivery should not differ from that offered to a general female population. Exclusive breastfeeding and early treatment reinitiation should be encouraged, with beta-interferons, glatiramer acetate and anti-CD20 monoclonal antibodies allowed in lactating women. Most DMTs require effective contraception and a pre-specified wash-out period before conception. On the other hand, beta-interferons, glatiramer acetate and dimethyl fumarate could be used until conception or even throughout pregnancy, as in the case of beta-interferons and glatiramer acetate. In females with highly active disease natalizumab could be continued until 34 gestational weeks, preferably every 6–8 weeks. Clinical implications. Family planning for women with MS requires an informed multi-disciplinary counselling. Neurologists are typically not trained in contraceptive use and family planning, while gynecologists and obstetricians are not aware of the most recent advances in MS immunotherapy. The aim of this statement is to provide multidisciplinary guidance in pregnancy planning and MS management during pregnancy and post-partum. Future directions. Family planning counselling should become part of routine MS care. Multidisciplinary approach is needed and should be encouraged with providing guidelines and educational resources to both, healthcare professionals and patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Neuroimmunology, Institute of Neurological Disorders, Poznan University of Medical Sciences, Poznan, Poland. akalinowska@ump.edu.pl.
- Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
- Department of Neurology, Collegium Medicum, University of Rzeszow, Rzeszow, Poland.
- Department of Neurology, Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
- Department of Neurology, Medical University of Bialystok, Bialystok, Poland.
- Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Alicja Kalinowska, Monika Adamczyk-Sowa, Halina Bartosik-Psujek, Waldemar Brola, Alina Kułakowska, Dagmara Mirowska-Guzel, Monika Nojszewska, Piotr Sieroszewski, Mariusz Stasiołek, Ewa Wender-Ożegowska
Zitieren
APA
Kalinowska, A., Adamczyk-Sowa, M., Bartosik-Psujek, H., Brola, W., Kułakowska, A., Mirowska-Guzel, D., Nojszewska, M., Sieroszewski, P., Stasiołek, M., Wawrzyniak, S., & Wender-Ożegowska, E. (2026). Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update. Neurologia i Neurochirurgia Polska, 60(5), 538-550. https://doi.org/10.5603/pjnns.111529
Vancouver
Kalinowska A, Adamczyk-Sowa M, Bartosik-Psujek H, Brola W, Kułakowska A, Mirowska-Guzel D, et al. Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update. Neurologia i Neurochirurgia Polska. 2026;60(5):538-550. doi:10.5603/pjnns.111529
BibTeX
@article{Kalinowska2026,
author = {Kalinowska, Alicja and Adamczyk-Sowa, Monika and Bartosik-Psujek, Halina and Brola, Waldemar and Kułakowska, Alina and Mirowska-Guzel, Dagmara and Nojszewska, Monika and Sieroszewski, Piotr and Stasiołek, Mariusz and Wawrzyniak, Sławomir and Wender-Ożegowska, Ewa},
title = {Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update},
journal = {Neurologia i Neurochirurgia Polska},
year = {2026},
volume = {60},
number = {5},
pages = {538--550},
doi = {10.5603/pjnns.111529}
}
EUVIMED